Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 117 | 0.91 |
| pathways Reactome | 1 pathway; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 13940
Sealed predictions
- GPX8 in dopamine neurons, braak+0.70 (p 0.034) → +0.36 (p 0.336)receipt 13946
Swarm cases
receipt 13946: GPX8 in dopamine neurons, braak
- power
- full sample +0.46 (p 0.054, n 18), 95% CI -0.01 to +0.76. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.38 (p 0.116, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.38 (p 0.123, n 18). could be the mix.
- skeptic
- leave-one-out range +0.40 to +0.62, sign flips 0; without severely affected donors +0.46 (p 0.054, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GPX8 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts